DNA Analysis
The advances in treatments have made it possible to include new genetic diseases to the panel of diseases eligible for neonatal screening. These diseases can be detected by finding the site of the specific DNA mutation.
LaCAR is developing its range and expanding its technology portfolio by adding qPCR to its already reputed enzyme range. The DNA analysis range includes kits for first-line neonatal screening suitable for the use of dried blood samples.



spectrometry Our Mass Spectrometry product line offers high-performance kits designed for sample multiplexing, enabling fast results with exceptional sensitivity.
You have a question regarding our products ? You want to know more about our method ?
Find out about our other expertises

